Kim Helen Susan

CIK 00014227729 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001422772

Recent Transactions

50 trades

Purchase
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12$18.00/sh+22,545→ 157,387 total
Conversion
Aktis Oncology, Inc.$AKTS
Series B Redeemable Convertible Preferred Stock
2026-01-12−3,648,750→ 0 total
Conversion
Aktis Oncology, Inc.$AKTS
Series A Redeemable Convertible Preferred Stock
2026-01-12−411,750→ 0 total
Conversion
Aktis Oncology, Inc.$AKTS
Series B Redeemable Convertible Preferred Stock
2026-01-12−101,250→ 0 total
Purchase
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12$18.00/sh+812,455→ 5,671,825 total
Conversion
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12+134,842→ 134,842 total
Conversion
Aktis Oncology, Inc.$AKTS
Series A Redeemable Convertible Preferred Stock
2026-01-12−14,838,250→ 0 total
Conversion
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12+4,859,370→ 4,859,370 total
Award
PROTHENA CORP PUBLIC LTD CO$PRTA
Stock Option (Right to Buy)
2025-05-14+20,183→ 20,183 total
Award
PROTHENA CORP PUBLIC LTD CO$PRTA
Stock Option (Right to Buy)
2024-05-15+15,000→ 15,000 total
Award
PROTHENA CORP PUBLIC LTD CO$PRTA
Stock Option (Right to Buy)
2023-05-17+15,000→ 15,000 total
Award
PROTHENA CORP PUBLIC LTD CO$PRTA
Stock Option (Right to Buy)
2022-08-31+30,000→ 30,000 total
Sale
Applied Molecular Transport Inc.
Common Stock
2021-08-27$31.44/sh−250→ 575,000 total
Sale
Applied Molecular Transport Inc.
Common Stock
2021-08-27$30.76/sh−701→ 575,250 total
Sale
Applied Molecular Transport Inc.
Common Stock
2021-08-26$31.01/sh−558→ 575,951 total
Sale
Applied Molecular Transport Inc.
Common Stock
2021-08-26$30.12/sh−13,505→ 576,509 total
Sale
Applied Molecular Transport Inc.
Common Stock
2021-08-25$30.08/sh−9,478→ 590,014 total
Sale
Applied Molecular Transport Inc.
Common Stock
2021-08-24$30.04/sh−3→ 599,492 total
Sale
Applied Molecular Transport Inc.
Common Stock
2021-08-24$30.03/sh−505→ 599,495 total
Sale
Applied Molecular Transport Inc.
Common Stock
2021-07-02$46.31/sh−1,241→ 600,000 total
Sale
Applied Molecular Transport Inc.
Common Stock
2021-07-02$43.30/sh−198,759→ 601,241 total
Award
Applied Molecular Transport Inc.
Stock Option (Right to Buy)
2021-05-18+14,343→ 14,343 total
Exercise/Conversion
Applied Molecular Transport Inc.
Stock Option (Right to Buy)
2020-07-02−800,000→ 0 total
Exercise/Conversion
Applied Molecular Transport Inc.
Common Stock
2020-07-02$0.02/sh+800,000→ 800,000 total
Award
ASSEMBLY BIOSCIENCES, INC.$ASMB
Stock Option (right to buy)
2020-06-11+10,000→ 10,000 total
Award
EXICURE, INC.$XCUR
Stock Option (right to buy)
2020-06-04+21,693→ 21,693 total
Award
EXICURE, INC.$XCUR
Stock Option (right to buy)
2019-06-14+21,693→ 21,693 total
Award
ASSEMBLY BIOSCIENCES, INC.$ASMB
Stock Option (right to buy)
2019-05-17+10,000→ 10,000 total
Award
EXICURE, INC.$XCUR
Stock Option (right to buy)
2018-06-19+21,693→ 21,693 total
Award
ASSEMBLY BIOSCIENCES, INC.$ASMB
Stock Option (right to buy)
2018-05-30+7,500→ 7,500 total
Award
ASSEMBLY BIOSCIENCES, INC.$ASMB
Stock Option (right to buy)
2018-03-08+20,000→ 20,000 total
Disposition from Tender
Kite Pharma, Inc.
Common Stock
2017-10-03$180.00/sh−4,193→ 17,500 total
Disposition to Issuer
Kite Pharma, Inc.
Common Stock
2017-10-03−17,500→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03−38,500→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03$116.13/sh−14,438→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03$128.57/sh−2,499→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03$126.10/sh−3,752→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03−52,500→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03−18,562→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-10-03−35,000→ 0 total
Award
EXICURE, INC.$XCUR
Stock Option (right to buy)
2017-09-26+24,824→ 24,824 total
Award
EXICURE, INC.$XCUR
Stock Option (right to buy)
2017-09-26+24,824→ 24,824 total
Award
EXICURE, INC.$XCUR
Stock Option (right to buy)
2017-09-26+49,649→ 49,649 total
Sale
Kite Pharma, Inc.
Common Stock
2017-09-25$179.66/sh−3,171→ 21,693 total
Award
Kite Pharma, Inc.
Common Stock
2017-09-25+6,000→ 24,864 total
Sale
Kite Pharma, Inc.
Common Stock
2017-08-10$120.09/sh−6,251→ 18,664 total
Exercise/Conversion
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-08-10−3,595→ 56,407 total
Exercise/Conversion
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-08-10−2,656→ 37,344 total
Exercise/Conversion
Kite Pharma, Inc.
Common Stock
2017-08-10$53.90/sh+3,595→ 22,259 total
Exercise/Conversion
Kite Pharma, Inc.
Common Stock
2017-08-10$51.43/sh+2,656→ 24,915 total

Companies

Recent Filings

Address

C/O AKTIS ONCOLOGY, INC. 17 DRYDOCK AVENUE, SUITE 17-401

BOSTON, MA, 02210

View on SEC.gov